SBWire

Regional variations in packaged food demand can be quite considerable and this has significant implications for ingredients supply. This report provides an overview of the market for packaged food ingredients, with particular reference to the differing needs of different regions around the world, examining key trends and developments in each of the seven major continental areas and highlighting the best opportunities for future growth.

Biogas Power in Canada, Market Outlook to 2025 - Capacity, Generation, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the biogas power market in Canada. The report provides in depth analysis on global renewable power market and global biogas power market with forecasts up to 2025. The report analyzes the power market scenario in Canada (includes thermal conventional, nuclear, large hydro and renewables) and provides future outlook with forecasts up to 2025. The research details renewable power market outlook in the country (includes wind, small hydro, biopower and solar PV) and provides forecasts up to 2025. The report highlights installed capacity, power generation and average number of homes powered during 2001-2025 in Canada biogas power market. A detailed coverage of renewable energy policy framework governing the market with specific policies pertaining to biogas power is provided in the report. The research also provides company snapshots of some of the major market participants.

This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Oman. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand balance for each of the key sub-segments. It also provides information relating to the crude oil assets (oil fields, refineries, pipelines and storage terminals) in Oman. The report compares the investment environment in Oman with other countries in the region. The profiles of the major companies operating in the crude oil sector in Oman together with the latest news and deals are also included in the report.

GlobalData's clinical trial report, "Acne Vulgaris Global Clinical Trials Review, H2, 2012" provides data on the Acne Vulgaris clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acne Vulgaris. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acne Vulgaris. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Books, News and Stationery Retailing in Asia-Pacific: Market Guide to 2016 provides in-depth detail on the trends and drivers of the Books, News and Stationery Retailing market in the Asia-Pacific. The report includes quantitative information (historic and forecast market values), segmented at category level.

Global Markets Direct's pharmaceuticals report, "Active Biotech AB - Product Pipeline Review - 2012" provides data on the Active Biotech AB's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Markets Direct's pharmaceuticals report, "OncoVista Innovative Therapies, Inc. - Product Pipeline Review - 2012" provides data on the OncoVista Innovative Therapies, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

The survey by the Financial Services Club on Payment Services Directive (PSD) and the Single Euro Payments Area (SEPA) gave a greater insight into the single payment system in the European region. Overall, 64% of banks and 67% of infrastructure providers believe interpretation at country level is an issue. The Austrian, Belgian, Swedish and Swiss all say there is no consistency of interpretation, and the Spanish and Swedish all state that the implementation is inconsistent.

An investigation on behalf of investors of Cymer, Inc. (NASDAQ:CYMI) in connection with the proposed takeover was announced and NASDAQ:CYMI stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com

A survey of likely voters in the key swing states of Nevada, North Carolina, Florida and Iowa reveals that the 2012 race for president between Barack Obama and Mitt Romney is tighter than ever, with a shrinking percentage of likely voters remaining undecided and therefore open to persuasion from either campaign.

Retail value and volume sales of pet food and pet products in Denmark continued to increase during 2011 and are set to do so again in 2012, which is mainly the result of the growing pet population on the one hand and the fact that many Danish consumers are willing to spend money when it comes to the well-being of their pets, on the other. The best performance in value terms was recorded in dog and cat treats, premium dry dog and cat food, pet healthcare and other pet products.

The Law Office of John C. Prezas is a Central Texas-based, general law firm known for defending the residents of Williamson and Travis County against a variety of criminal charges. As a DWI and DUI defense lawyer. Already known for drug defense, juvenile defense, traffic and probation violations and other misdemeanor and felony crimes; now the Prezas office is proud to announce a new Juvenile Crime FAQ on its website to help inform consumers about juvenile crimes and to enable parents to better protect their children’s’ rights.

Global Markets Direct's, 'Other Gastrointestinal Disorders - Pipeline Review, H2 2012', provides an overview of the Other Gastrointestinal Disorders therapeutic pipeline. This report provides information on the therapeutic development for Other Gastrointestinal Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Other Gastrointestinal Disorders. 'Other Gastrointestinal Disorders - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012', provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) therapeutic pipeline. This report provides information on the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD). 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Mycobacterium Infections - Pipeline Review, H2 2012', provides an overview of the Mycobacterium Infections therapeutic pipeline. This report provides information on the therapeutic development for Mycobacterium Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Mycobacterium Infections. 'Mycobacterium Infections - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Osteoarthritis - Pipeline Review, H2 2012', provides an overview of the Osteoarthritis therapeutic pipeline. This report provides information on the therapeutic development for Osteoarthritis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Osteoarthritis. 'Osteoarthritis - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Myelodysplastic Syndrome - Pipeline Review, H2 2012', provides an overview of the Myelodysplastic Syndrome therapeutic pipeline. This report provides information on the therapeutic development for Myelodysplastic Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Myelodysplastic Syndrome. 'Myelodysplastic Syndrome - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Hemophilia - Pipeline Review, H2 2012', provides an overview of the Hemophilia therapeutic pipeline. This report provides information on the therapeutic development for Hemophilia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hemophilia. 'Hemophilia - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Ulcerative Colitis - Pipeline Review, H2 2012', provides an overview of the Ulcerative Colitis therapeutic pipeline. This report provides information on the therapeutic development for Ulcerative Colitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ulcerative Colitis. 'Ulcerative Colitis - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Complicated Skin And Skin Structure Infections (cSSSI) - Pipeline Review, H2 2012', provides an overview of the Complicated Skin And Skin Structure Infections (cSSSI) therapeutic pipeline. This report provides information on the therapeutic development for Complicated Skin And Skin Structure Infections (cSSSI), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Complicated Skin And Skin Structure Infections (cSSSI). 'Complicated Skin And Skin Structure Infections (cSSSI) - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Other Respiratory Disorders - Pipeline Review, H2 2012', provides an overview of the Other Respiratory Disorders therapeutic pipeline. This report provides information on the therapeutic development for Other Respiratory Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Other Respiratory Disorders. 'Other Respiratory Disorders - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

“Thin Film and Printed Battery Market, Global Forecast & Analysis (2012 - 2017) by Technology (Substrate type, Electrolyte type, Cathode type), Products (Voltage types, Rechargeability, Integration type), & Applications (Commercial, Industrial, Consumer)”

Tissue and hygiene recorded slightly slower growth during 2011, with consumers trying to cope with the higher level of inflation, coupled with the higher prices of utilities and transportation. However, growth was supported by the still dynamic, albeit slower, expansion of the two biggest categories - nappies/diapers/pants and sanitary protection. This performance was also stimulated by Filipino middle-income consumers becoming more concerned about convenience.

The rising incidence of cancer is continuing to drive intense R&D interest in oncology. Drug developers are shifting their attention towards the development of novel therapies for molecularly defined patient populations. The future will increasingly see the approval of targeted therapies for specific molecular aberrations and the incorporation of companion diagnostics in routine clinical practice.

The search for innovative card products has been a major focus in the past decade. However, the importance of customer retention for credit card issuers has grown in the wake of the global economic slowdown. The switch towards debit and cash spending in mature markets, the emergence of a range of new payment channels, increase in legislation and the continuing trend for customers to reduce consumption all present significant obstacles to the credit card industry. Credit card issuers in the US took drastic measures during the recession, such as making it harder for consumers to compare credit card offers online and more expensive to transfer balances to other providers. Issuers also cut back their cooperation with comparison sites and raised fees for balance transfers. While such actions were stop-gap measures, and not necessarily indicative of mature retention strategies, they do attest to the increasing importance being placed on card retention in today's economic climate.